ReviewBMJ neurology open2026

Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety.

Peter Bradhurst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.